My name is Karina Pasquevich, and I am an Argentinian scientist, born in La Plata on June 13, 1978. I earned my degree in Biochemistry from the National University of La Plata in 2003 and completed my Ph.D. in Immunology at the University of Buenos Aires in 2009. My doctoral research, under the supervision of Dr. Juliana Cassataro, focused on the development of vaccines for Brucellosis and was carried out at the Institute of Humoral Immunity Research (IDEHU) and the Immunogenetics Laboratory at the Hospital de Clínicas, UBA. Between 2010 and 2011, I worked as a postdoctoral fellow at the University of Tübingen in Germany, with funding from the Alexander von Humboldt Foundation. During that time, I studied bacterial infections and their effects on immune cell development. In 2012, I joined Dr. Cassataro’s group as an assistant researcher at CONICET, and I currently work as an independent researcher at the Institute for Biotechnology Research (IIB-INTECH) at the National University of San Martín. Since the beginning of my scientific career, I have focused on vaccine development, with a particular interest in the design and application of novel vaccine adjuvants. I have published 38 peer-reviewed scientific papers, co-authored two patents on vaccine adjuvants (one granted, one pending), and led three research grants as principal investigator. I have also been actively involved in the development of ARVAC, a recombinant subunit vaccine against COVID-19, which has been approved for human use in Argentina.